SCRI Tennessee Oncology - Nashville — Nashville, Tennessee

SCRI Tennessee Oncology - Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI Tennessee Oncology - Nashville has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung.

Sponsors: Arcus Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Tennessee Oncology - Nashville?

SCRI Tennessee Oncology - Nashville has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Tennessee Oncology - Nashville conducted?

SCRI Tennessee Oncology - Nashville has 2 clinical trials on record, with 1 currently active. Their work covers Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung.

Is SCRI Tennessee Oncology - Nashville accredited by Crixeo Health?

SCRI Tennessee Oncology - Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Tennessee Oncology - Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.